NO984713L - Nye karboksylsyre-derivater, deres fremstilling og anvendelse - Google Patents
Nye karboksylsyre-derivater, deres fremstilling og anvendelseInfo
- Publication number
- NO984713L NO984713L NO984713A NO984713A NO984713L NO 984713 L NO984713 L NO 984713L NO 984713 A NO984713 A NO 984713A NO 984713 A NO984713 A NO 984713A NO 984713 L NO984713 L NO 984713L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- carboxylic acid
- acid derivatives
- new carboxylic
- new
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19614542A DE19614542A1 (de) | 1996-04-12 | 1996-04-12 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| PCT/EP1997/001687 WO1997038982A1 (de) | 1996-04-12 | 1997-04-04 | Neue carbonsäurederivate, ihre herstellung und verwendung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO984713L true NO984713L (no) | 1998-10-09 |
| NO984713D0 NO984713D0 (no) | 1998-10-09 |
| NO311802B1 NO311802B1 (no) | 2002-01-28 |
Family
ID=7791123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19984713A NO311802B1 (no) | 1996-04-12 | 1998-10-09 | Nye karboksylsyre-derivater og deres anvendelse |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6103732A (no) |
| EP (1) | EP0892788A1 (no) |
| JP (1) | JP2000508325A (no) |
| KR (1) | KR20000005366A (no) |
| CN (1) | CN1216042A (no) |
| AR (1) | AR006593A1 (no) |
| AU (1) | AU711293B2 (no) |
| BG (1) | BG63202B1 (no) |
| BR (1) | BR9708614A (no) |
| CA (1) | CA2250764A1 (no) |
| CO (1) | CO4900038A1 (no) |
| DE (1) | DE19614542A1 (no) |
| HR (1) | HRP970200A2 (no) |
| ID (1) | ID19050A (no) |
| IL (1) | IL126026A0 (no) |
| NO (1) | NO311802B1 (no) |
| NZ (1) | NZ331704A (no) |
| PL (1) | PL329240A1 (no) |
| SK (1) | SK127698A3 (no) |
| TR (1) | TR199802042T2 (no) |
| TW (1) | TW419465B (no) |
| WO (1) | WO1997038982A1 (no) |
| ZA (1) | ZA973096B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448248B1 (en) | 1996-12-18 | 2002-09-10 | Abbott Laboratories | Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
| JP2001514254A (ja) * | 1997-09-04 | 2001-09-11 | ビーエーエスエフ アクチェンゲゼルシャフト | 新規カルボン酸誘導体、その製造及び混合ｅｔａ／ｅｔｂエンドセリン受容体拮抗薬としてのその使用 |
| DE69830069T3 (de) * | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel |
| US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
| ES2262567T3 (es) * | 2001-03-20 | 2006-12-01 | Schwarz Pharma Ag | Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico. |
| DK1243263T3 (da) * | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
| EA013591B1 (ru) | 2004-04-16 | 2010-06-30 | Шварц Фарма Аг | Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd) |
| EP1781276B1 (en) * | 2004-08-27 | 2010-06-23 | UCB Pharma GmbH | Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| AR061476A1 (es) * | 2006-06-15 | 2008-08-27 | Sanol Arznei Schwarz Gmbh | Composicion farmaceutica con efecto anticonvulsivo sinergico |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| WO1996000219A1 (en) * | 1994-06-27 | 1996-01-04 | Ciba-Geigy Ag | Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides |
-
1996
- 1996-04-12 DE DE19614542A patent/DE19614542A1/de not_active Withdrawn
-
1997
- 1997-04-04 AU AU26364/97A patent/AU711293B2/en not_active Ceased
- 1997-04-04 EP EP97918109A patent/EP0892788A1/de not_active Withdrawn
- 1997-04-04 CN CN97193737A patent/CN1216042A/zh active Pending
- 1997-04-04 JP JP9536698A patent/JP2000508325A/ja active Pending
- 1997-04-04 BR BR9708614A patent/BR9708614A/pt not_active IP Right Cessation
- 1997-04-04 US US09/155,948 patent/US6103732A/en not_active Expired - Fee Related
- 1997-04-04 NZ NZ331704A patent/NZ331704A/en unknown
- 1997-04-04 PL PL97329240A patent/PL329240A1/xx unknown
- 1997-04-04 TR TR1998/02042T patent/TR199802042T2/xx unknown
- 1997-04-04 SK SK1276-98A patent/SK127698A3/sk unknown
- 1997-04-04 KR KR1019980708088A patent/KR20000005366A/ko not_active Application Discontinuation
- 1997-04-04 IL IL12602697A patent/IL126026A0/xx unknown
- 1997-04-04 CA CA002250764A patent/CA2250764A1/en not_active Abandoned
- 1997-04-04 WO PCT/EP1997/001687 patent/WO1997038982A1/de not_active Application Discontinuation
- 1997-04-10 AR ARP970101432A patent/AR006593A1/es not_active Application Discontinuation
- 1997-04-11 HR HR19614542.2A patent/HRP970200A2/xx not_active Application Discontinuation
- 1997-04-11 CO CO97018895A patent/CO4900038A1/es unknown
- 1997-04-11 TW TW086104674A patent/TW419465B/zh not_active IP Right Cessation
- 1997-04-11 ZA ZA973096A patent/ZA973096B/xx unknown
- 1997-04-14 ID IDP971240A patent/ID19050A/id unknown
-
1998
- 1998-09-15 BG BG102770A patent/BG63202B1/bg unknown
- 1998-10-09 NO NO19984713A patent/NO311802B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP970200A2 (en) | 1998-04-30 |
| PL329240A1 (en) | 1999-03-15 |
| US6103732A (en) | 2000-08-15 |
| TR199802042T2 (xx) | 2000-09-21 |
| BR9708614A (pt) | 1999-08-03 |
| AR006593A1 (es) | 1999-09-08 |
| IL126026A0 (en) | 1999-05-09 |
| CO4900038A1 (es) | 2000-03-27 |
| SK127698A3 (en) | 2000-03-13 |
| NO311802B1 (no) | 2002-01-28 |
| TW419465B (en) | 2001-01-21 |
| BG63202B1 (bg) | 2001-06-29 |
| JP2000508325A (ja) | 2000-07-04 |
| KR20000005366A (ko) | 2000-01-25 |
| NZ331704A (en) | 2000-06-23 |
| EP0892788A1 (de) | 1999-01-27 |
| WO1997038982A1 (de) | 1997-10-23 |
| NO984713D0 (no) | 1998-10-09 |
| BG102770A (en) | 1999-11-30 |
| CA2250764A1 (en) | 1997-10-23 |
| CN1216042A (zh) | 1999-05-05 |
| AU711293B2 (en) | 1999-10-07 |
| ZA973096B (en) | 1998-10-12 |
| DE19614542A1 (de) | 1997-10-16 |
| AU2636497A (en) | 1997-11-07 |
| ID19050A (id) | 1998-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991761D0 (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO963499D0 (no) | Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav | |
| NO20015113L (no) | Nye forbindelser, deres fremstilling og anvendelse | |
| NO20022289L (no) | Ny anvendelse og nye N-azabisykloamidderivater | |
| NO975711L (no) | Nye Dolastatinderivater, deres fremstilling og anvendelse | |
| DK0911340T3 (da) | Substituerede isoquinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel | |
| NO20005266D0 (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
| DK0836615T3 (da) | Nye thrombininhibitorer, deres fremstilling og anvendelse | |
| NO984717L (no) | Nye hydroksamsyre-derivater, deres fremstilling og anvendelse | |
| NO984714D0 (no) | Nye karboksylsyre-derivater, deres fremstilling og anvendelse | |
| NO984713L (no) | Nye karboksylsyre-derivater, deres fremstilling og anvendelse | |
| NO951147D0 (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
| NO20001934D0 (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| DK0410358T3 (da) | Aromatiske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler | |
| NO992976D0 (no) | Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister | |
| NO984624D0 (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| NO951811D0 (no) | Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse | |
| NO981002L (no) | Karboksylsyrederivater, deres fremstilling og anvendelse | |
| NO971424D0 (no) | Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse | |
| NO992690L (no) | Nye calpainer, fremstilling og anvendelse derav | |
| NO20003128D0 (no) | Nye p-aminofenylderivater og deres anvendelse | |
| NO972822D0 (no) | Fluoralkylglycosiduronsyrer og tilsvarende 6(3)-lactoner, deres fremstilling og anvendelse | |
| NO965553D0 (no) | Nye anidokinoksalin-dioner, deres fremstilling og anvendelse | |
| DK0862550T3 (da) | Hidtil ukendte carboxylsyrederivater, deres fremstilling og anvendelse | |
| NO982349D0 (no) | Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN OCTOBER 2003 |